Peptide-Directed Highly Selective Targeting of Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a disorder of the pulmonary vasculature associated with elevated pulmonary vascular resistance. Despite recent advances in the treatment of PAH, with eight approved clinical therapies and additional therapies undergoing clinical trials, PAH remains a serious...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Urakami, Takeo, Järvinen, Tero A.H., Toba, Michie, Sawada, Junko, Ambalavanan, Namasivayam, Mann, David, McMurtry, Ivan, Oka, Masahiko, Ruoslahti, Erkki, Komatsu, Masanobu
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Investigative Pathology 2011
Konular:
Short Communication
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3123986/
https://ncbi.nlm.nih.gov/pubmed/21549345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajpath.2011.02.032
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller